- Home
- CMBT vs SDGR Comparison
CMBT vs SDGR Comparison
Compare CMBT & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMBT
- SDGR
- Stock Information
- Founded
- CMBT 1989
- SDGR 1990
- Country
- CMBT Belgium
- SDGR United States
- Employees
- CMBT N/A
- SDGR N/A
- Industry
- CMBT
- SDGR Biotechnology: Pharmaceutical Preparations
- Sector
- CMBT
- SDGR Health Care
- Exchange
- CMBT NYSE
- SDGR Nasdaq
- Market Cap
- CMBT 1.9B
- SDGR 1.8B
- IPO Year
- CMBT N/A
- SDGR 2020
- Fundamental
- Price
- CMBT $8.91
- SDGR $23.91
- Analyst Decision
- CMBT
- SDGR Buy
- Analyst Count
- CMBT 0
- SDGR 5
- Target Price
- CMBT N/A
- SDGR $32.80
- AVG Volume (30 Days)
- CMBT 139.5K
- SDGR 1.6M
- Earning Date
- CMBT 05-16-2025
- SDGR 05-07-2025
- Dividend Yield
- CMBT 64.05%
- SDGR N/A
- EPS Growth
- CMBT 4.48
- SDGR N/A
- EPS
- CMBT 4.44
- SDGR N/A
- Revenue
- CMBT $940,246,000.00
- SDGR $230,492,000.00
- Revenue This Year
- CMBT $5.05
- SDGR $24.12
- Revenue Next Year
- CMBT $24.22
- SDGR $18.60
- P/E Ratio
- CMBT $2.07
- SDGR N/A
- Revenue Growth
- CMBT N/A
- SDGR 22.29
- 52 Week Low
- CMBT $7.65
- SDGR $16.60
- 52 Week High
- CMBT $21.26
- SDGR $28.47
- Technical
- Relative Strength Index (RSI)
- CMBT 45.76
- SDGR 49.40
- Support Level
- CMBT $9.25
- SDGR $22.69
- Resistance Level
- CMBT $9.92
- SDGR $24.92
- Average True Range (ATR)
- CMBT 0.36
- SDGR 1.38
- MACD
- CMBT 0.01
- SDGR -0.33
- Stochastic Oscillator
- CMBT 27.11
- SDGR 26.64
About CMBT EURONAV
CMB.Tech NV owns and operates a fleet of vessels for international maritime shipping and storage of crude oil and petroleum products. It generate a large parts of their revenue from voyage charters, including vessels in pools that predominantly perform voyage charters. The company organizes itself into three divisons: the Marine division, the H2 Infra division and the H2 Industry division. The Marine Division derives maximum revenue.
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.